TickerFacts.

Filana Therapeutics, Inc. (FLNA): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2012-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

48.31M
As of 2025-12-31
48.31M
As of 2026-03-31
+5.0%
3-year compound annual growth
+6.5%
5-year compound annual growth
+0.5%
10-year compound annual growth
2010-12-31: 42.91M2011-12-31: 44.73M2012-12-31: 45.33M2013-12-31: 45.51M2014-12-31: 45.76M2015-12-31: 45.76M2016-12-31: 6.59M2017-12-31: 6.60M2018-12-31: 17.22M2019-12-31: 21.84M2020-12-31: 35.24M2021-12-31: 40.02M2022-12-31: 41.74M2023-12-31: 42.24M2024-12-31: 48.20M2025-12-31: 48.31M48.31M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3148.31M+0.2%2026-03-12, Balance as of period end
2024-12-3148.20M+14.1%2026-03-12, Balance as of period end
2023-12-3142.24M+1.2%2025-03-03, Balance as of period end
2022-12-3141.74M+4.3%2024-02-28, Balance as of period end
2021-12-3140.02M+13.6%2023-02-28, Balance as of period end
2020-12-3135.24M+61.3%2022-03-01, Balance as of period end
2019-12-3121.84M+26.8%2021-03-23, Balance as of period end
2018-12-3117.22M+161.1%2020-03-26, Balance as of period end
2017-12-316.60M+0.1%2019-03-29, Balance as of period end
2016-12-316.59M-85.6%2018-02-06, Balance as of period end
2015-12-3145.76M0.0%2017-03-07, Balance as of period end
2014-12-3145.76M+0.5%2016-03-03, Balance as of period end
2013-12-3145.51M+0.4%2015-02-18, Balance as of period end
2012-12-3145.33Mn/c2014-02-05, Balance as of period end
2011-12-3144.73M+4.2%2013-02-08, Balance as of period end
2010-12-3142.91Mn/a2012-02-09, Balance as of period end